Microfluidic Device Using Electric Field Gradient for Gene Expression Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic systems lack the necessary control and flexibility to manipulate biological processes, particularly gene expression, at a small scale.

Innovation Solution

A method involving a microfluidic device with a test chamber where an electric field gradient is applied to control biological processes. Non-immobilized components are drawn away from immobilized components towards the source of the electric field, allowing for precise control of processes like DNA transcription and gene expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If microfluidic systems are used to perform biochemical analyses and syntheses, then time, cost and space requirements are substantially reduced, but control and flexibility to manipulate biological processes are insufficient

Engineering Contradiction:
Improvetime requirementsVSAvoidcontrol and flexibility
Core Design Contradiction:
Loss of timeVSAdaptability or versatility

Solution Approach 1:

The patent applies dynamic control through electric field gradients that can be adjusted in real-time to manipulate biomolecule positions and interactions within the microfluidic device, enabling flexible control of biological processes while maintaining miniaturization benefits

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent changes physical parameters by applying electric field gradients to alter the behavior of biomolecules in the microfluidic system, providing a new degree of control over biochemical reactions without increasing device size or complexity

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If electric field gradient is applied to control biological processes, then precise regulation of gene expression is achieved, but device complexity increases

Engineering Contradiction:
Improveprecise regulationVSAvoiddevice complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent integrates electric field gradient capability into the existing microfluidic device structure, allowing the same device to perform both fluid manipulation and electromagnetic control of biomolecules, thereby reducing overall system complexity while achieving precise regulation

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The application of an electric field gradient effectively controls biological processes by depleting essential machinery from the reaction site, allowing for precise regulation of gene expression and protein synthesis.

Implementation Method 1

applying an electric field gradient in the test chamber at a frequency which draws at least one non-immobilized component of the biological process away from the at least one immobilized component towards the source of the electric field gradient

Methodology Applied
Scientific EffectElectric field gradient: Electric Field

Data Source

PatentUS20250114788A1Use of electric field gradients to control gene expression
Publication Date: 2025.04.10 YEDA RES & DEV CO LTD
  • US20250114788A1 patent drawing
  • US20250114788A1 patent drawing
  • US20250114788A1 patent drawing

AI summary

Methods of controlling biological processes by altering the electric field gradient in a test chamber are disclosed. A portion of a surface of the test chamber is attached to at least one immobilized component of the biological process. Microfluidic devices capable of same are also disclosed.